No registrations found.
ID
Source
Health condition
COPD GOLD D
Sponsors and support
Intervention
Outcome measures
Primary outcome
WP1:
- We aim to describe the baseline characteristics of GOLD D patients.
WP2:
-We aim to identify the difference in health status between baseline and final follow up at 12 months, as measured by the CCQ and CAT.
Secondary outcome
WP1:
We will compare the baseline characteristics of GOLD D patients with those of GOLD group A, B, and C patients.
• We will compare GOLD D patients as assessed using either CCQ ≥ 1 or CAT ≥ 10 criteria.
• We will evaluate how representative the Certe AC Service patients are of the wider COPD population by comparing their characteristics with those of patients in the UNLOCK initiative.
WP2:
• We aim to identify the patient characteristics associated with changes in quality of life, thereby seeking to validate the known patient phenotypes, such as frequent exacerbators, patients with rapid decline in FEV1, patients with low body mass index, and those with poor exercise capacity.
Gold D in primary care
Version 3, 10th June 2015 12 of 28
• We will compare the following variables between the year preceding the study and the study period:
o Differences in exacerbation rates;
o Differences in health care costs;
o Differences in medication use; and
o Differences in patient characteristics between gold d and gold a, b and c patients.
• Using data based on their usual care, we also aim to identify the characteristics of patients that change classification within the study period, as follows:
o Those changing from GOLD D to another GOLD group (A, B, or C) versus those that remain unchanged, and;
o Those changing from GOLD group A, B or C to another GOLD group versus those that remain unchanged.
Study objective
We hypothesise that accurate treatment of GOLD D patients in an integrated primary care system will improve patient outcomes over 12 months.
Study design
Last patient in: january 2016
Last patient last visit: april 2017
Final publication ready for submission: november 2017
Intervention
Treatment in the integrated care system of Certe (AC Service) for 12 months
C. Jong, de
Medicine Department of Primary Care University Medical Centre Groningen, Hanzeplein 1
Groningen 9700 RB
The Netherlands
C. Jong, de
Medicine Department of Primary Care University Medical Centre Groningen, Hanzeplein 1
Groningen 9700 RB
The Netherlands
Inclusion criteria
• Age > 40 (all patients)
• Diagnosed COPD (work package 1)
• Diagnosis compatible with GOLD D classification (work package 2)
Exclusion criteria
• Asthma diagnosis, asthma/COPD overlap syndrome or other respiratory illnesses
• Inability to complete questionnaires due to language or cognitive difficulties
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL5361 |
| NTR-old | NTR5626 |
| Other | METC : 2014.498 |